×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
OTCMKTS:SARTF

Sartorius Aktiengesellschaft Stock Forecast, Price & News

$331.00
0.00 (0.00%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$331.00
$331.00
50-Day Range
$292.00
$403.13
52-Week Range
$292.00
$947.00
Volume
N/A
Average Volume
17 shs
Market Capitalization
$11.33 billion
P/E Ratio
44.19
Dividend Yield
N/A
Price Target
N/A

Sartorius Aktiengesellschaft Stock Forecast (MarketRank)

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
14.56%
From $10.37 to $11.88 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.72 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive SARTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Sartorius Aktiengesellschaft logo

About Sartorius Aktiengesellschaft (OTCMKTS:SARTF)

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

SARTF Stock News Headlines

Sartorius Aktiengesellschaft (SRT.DE)
Sartorius To Join The DAX Blue Chip Index
Sartorius acquires cell culture specialist Xell AG
What Makes SARTORIUS AG (SARTF) a New Buy Stock
Sartorius closes acquisition of BIA Separations
See More Headlines

Industry, Sector and Symbol

Industry
Dental equipment & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:SARTF
Previous Symbol
NASDAQ:SARTF
CIK
N/A
Employees
13,832
Year Founded
N/A

Company Calendar

Last Earnings
4/21/2022
Today
7/03/2022
Fiscal Year End
12/31/2022

Profitability

Net Income
$377.28 million
Pretax Margin
22.80%

Debt

Sales & Book Value

Annual Sales
$4.08 billion
Cash Flow
$27.11 per share
Book Value
$59.46 per share

Miscellaneous

Free Float
N/A
Market Cap
$11.33 billion
Optionable
Not Optionable
Beta
0.74














Sartorius Aktiengesellschaft Frequently Asked Questions

Should I buy or sell Sartorius Aktiengesellschaft stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sartorius Aktiengesellschaft in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Sartorius Aktiengesellschaft stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SARTF, but not buy additional shares or sell existing shares.
View analyst ratings for Sartorius Aktiengesellschaft
or view top-rated stocks.

How has Sartorius Aktiengesellschaft's stock price performed in 2022?

Sartorius Aktiengesellschaft's stock was trading at $530.76 at the start of the year. Since then, SARTF stock has decreased by 37.6% and is now trading at $331.00.
View the best growth stocks for 2022 here
.

How were Sartorius Aktiengesellschaft's earnings last quarter?

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) announced its quarterly earnings results on Thursday, April, 21st. The company reported $2.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.49 by $0.25. The business had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.06 billion. Sartorius Aktiengesellschaft had a net margin of 11.99% and a trailing twelve-month return on equity of 33.80%.
View Sartorius Aktiengesellschaft's earnings history
.

Who are Sartorius Aktiengesellschaft's key executives?

Sartorius Aktiengesellschaft's management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 57, Pay $1.92M)
  • Mr. Rainer Lehmann, CFO, Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 47, Pay $967.42k)
  • Mr. John Gerard Mackay, Head of Lab Products & Services Division and Member of Exec. Board (Age 60, Pay $928.64k)
  • Dr. Rene Faber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 47, Pay $820.91k)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 53, Pay $61.41k)
  • Mr. Manfred Werner, Sr. VP of Admin. Organization & Auditing
  • Ms. Mei Wang, Head of Production - China
  • Ms. Patricia Spannagel, Head of Quality Assurance - Mechatronics Division Goettingen
  • Mr. Rashid Maqbool, Head of Production & Certification Department - Denver USA
  • Mr. Manohar Kuppusami, Head of Production Department - India

Who are some of Sartorius Aktiengesellschaft's key competitors?

What is Sartorius Aktiengesellschaft's stock symbol?

Sartorius Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "SARTF."

How do I buy shares of Sartorius Aktiengesellschaft?

Shares of SARTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sartorius Aktiengesellschaft's stock price today?

One share of SARTF stock can currently be purchased for approximately $331.00.

How much money does Sartorius Aktiengesellschaft make?

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) has a market capitalization of $11.33 billion and generates $4.08 billion in revenue each year. The company earns $377.28 million in net income (profit) each year or $7.49 on an earnings per share basis.

How many employees does Sartorius Aktiengesellschaft have?

Sartorius Aktiengesellschaft employs 13,832 workers across the globe.

How can I contact Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft's mailing address is OTTO-BRENNER-STRASSE 20, GOETTINGEN 2M, 37079. The official website for Sartorius Aktiengesellschaft is www.sartorius.com. The company can be reached via phone at 495513080, via email at ben.orzelek@sartorius.com, or via fax at 49-55-1308-3289.

This page (OTCMKTS:SARTF) was last updated on 7/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.